NCT04018378View on ClinicalTrials.gov

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

May 15, 2017

Study Completion Date

September 17, 2018

Conditions
Healthy
Interventions
DRUG

varenicline tartrate 1mg (HGP1604, R) - varenicline oxalate 1mg (HIP1502, T), RT

varenicline tartrate 1mg (HGP1604) was used as a reference drug and varenicline oxalate 1mg (HIP1502) was used as a test drug.

DRUG

varenicline oxalate 1mg (HIP1502, T) - varenicline tartrate 1mg (HGP1604, R), TR

varenicline tartrate 1mg (HGP1604) was used as a reference drug and varenicline oxalate 1mg (HIP1502) was used as a test drug.

Trial Locations (1)

136-705

Dept. of Clinical Pharmacology & Toxicology, Anam Hospital, Korea University College of Medicine, Seoul

All Listed Sponsors
lead

Korea University Anam Hospital

OTHER

NCT04018378 - A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502 | Biotech Hunter | Biotech Hunter